Life Science

From the current challenges facing us with the global pandemic to future medical needs, Chelsea’s expertise in optical design can help improve diagnostic capability in the life sciences sector.

With a rich history of contract design and manufacture for biotech companies, encompassing laboratory instrumentation, point of care diagnostics and even veterinary equipment, Chelsea is ideally placed to deliverBrightline Dx is a joint venture formed by two highly innovative UK companies, Stream Bio and Chelsea Technologies, to combine novel technologies and create a unique platform that can be applied to a wide range of diagnostic targets. The Joint Venture’s immediate focus is a highly sensitive saliva based Covid-19 test, capable of rapid identification of Covid-19, including detection of low viral loads typically found in asymptomatic carriers. highly sensitive optical reader technology into the life sciences sector and beyond.

See all

All Life Science